212 related articles for article (PubMed ID: 19912677)
1. [Advance in the management of the difficult-to-treat patients with chronic hepatitis C].
Xie Y; Li MH
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):484-6. PubMed ID: 19912677
[No Abstract] [Full Text] [Related]
2. [Treatment for chronic hepatitis C, more opportunity, more challenge].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676
[No Abstract] [Full Text] [Related]
3. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678
[No Abstract] [Full Text] [Related]
4. [The study of optimal treatment in patients with refractory chronic hepatitis C].
Chen XY; Zhang YH
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):488-9. PubMed ID: 19912679
[No Abstract] [Full Text] [Related]
5. [Therapy of chronic Hepatitis C in 2008].
Niederau C; Kaden T
MMW Fortschr Med; 2008 Mar; 150(13):31-4. PubMed ID: 18522354
[No Abstract] [Full Text] [Related]
6. Customizing treatment to patient populations.
Brown RS
Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4 Suppl 1():S3-9. PubMed ID: 17235282
[TBL] [Abstract][Full Text] [Related]
7. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].
Lopukhova NL
Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502
[No Abstract] [Full Text] [Related]
8. [Individualization of antiviral treatment of chronic hepatitis].
Konstantinov DIu; Konstantinova EA; Strebkova EA; Popova LL; Suzdal'tsev AA
Eksp Klin Gastroenterol; 2013; (6):29-34. PubMed ID: 24772857
[No Abstract] [Full Text] [Related]
9. [Predictive value of virological response on sustained virological response in hepatitis C patients].
Zhou YQ; Wang XH; Fan Y; Zhu Y; Tan WT; Mao Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):944-6. PubMed ID: 20038340
[No Abstract] [Full Text] [Related]
10. ADVANCE study begins enrollment.
AIDS Patient Care STDS; 2008 Apr; 22(4):345. PubMed ID: 18422463
[No Abstract] [Full Text] [Related]
11. Response-guided therapy: optimizing treatment now and in the future.
Marcellin P; Rizzetto M
Antivir Ther; 2008; 13 Suppl 1():1-2. PubMed ID: 18432156
[No Abstract] [Full Text] [Related]
12. Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
Lagging M; Langeland N; Pedersen C; Färkkilä M; Buhl MR; Mørch K; Dhillon AP; Alsiö A; Hellstrand K; Westin J; Christensen P; Leutscher P; Norkrans G;
Hepatology; 2008 Aug; 48(2):695. PubMed ID: 18666232
[No Abstract] [Full Text] [Related]
13. [High dose repeat therapy in previously treated patients with chronic hepatitis C].
Hoepffner N; Paul KA; Nikodem AB; Teuber G
Dtsch Med Wochenschr; 2006 Mar; 131(11):543-4. PubMed ID: 16538557
[No Abstract] [Full Text] [Related]
14. [Peginterferon alpha and ribavirin therapy for difficult-to-treat chronic hepatitis C patients].
Pawłowska M; Halota W
Przegl Epidemiol; 2002; 56 Suppl 4():51-4. PubMed ID: 14750261
[No Abstract] [Full Text] [Related]
15. The treatment of viral hepatitis, present and future.
Rodés J
J Hepatobiliary Pancreat Surg; 2003; 10(2):163-7. PubMed ID: 14505150
[No Abstract] [Full Text] [Related]
16. Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with HIV.
Rachline A; Palmer P; Simon F; Molina JM
J Med Virol; 2010 Jul; 82(7):1150-1. PubMed ID: 20513077
[TBL] [Abstract][Full Text] [Related]
17. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
[TBL] [Abstract][Full Text] [Related]
18. Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we?
Hu KQ; Zhang YY
J Clin Gastroenterol; 2014 Jan; 48(1):3-5. PubMed ID: 24045272
[No Abstract] [Full Text] [Related]
19. [Prediction of sustained viral response to combinational therapy with interferon and ribavirin in chronic hepatitis C by rapid viral response].
Li MH; Chen LJ; Qiu GH; Lu Y; Xie Y; Xu DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):497-500. PubMed ID: 19912682
[TBL] [Abstract][Full Text] [Related]
20. PEG-IFN, RBV dosing during chronic HCV re-treatment.
Highleyman L
IAPAC Mon; 2007 Feb; 13(2):55. PubMed ID: 17948601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
